Home

The Korea Herald

Latest news

Most Popular

  1. 1

    Traffic delays expected as railway workers stage slowdown

    Traffic delays expected as railway workers stage slowdown
  2. 2

    [Campus Now] Women's colleges in crisis: Blasted for gender bias, coed transition proposals

    [Campus Now] Women's colleges in crisis: Blasted for gender bias, coed transition proposals
  3. 3

    Seoul mulls hiring foreign nationals as local bus drivers

    Seoul mulls hiring foreign nationals as local bus drivers
  4. 4

    W10tr buyback plan fires up Samsung stock

    W10tr buyback plan fires up Samsung stock
  5. 5

    ‘Hangang River,’ not 'Han River': Seoul city

    ‘Hangang River,’ not 'Han River': Seoul city
  1. 6

    Carmakers, battery suppliers vie for leadership in battery management

    Carmakers, battery suppliers vie for leadership in battery management
  2. 7

    Kim Jong-un orders full war readiness to justify NK troop deployments: Seoul

    Kim Jong-un orders full war readiness to justify NK troop deployments: Seoul
  3. 8

    Why are Yale students taking K-pop classes?

    Why are Yale students taking K-pop classes?
  4. 9

    DP leader indicted again over alleged misuse of public funds

    DP leader indicted again over alleged misuse of public funds
  5. 10

    [From the Scene] Climate change threatens Jeju's mandarin orange business

    [From the Scene] Climate change threatens Jeju's mandarin orange business
지나쌤

LifeSignals receives FDA 510 (k) Approval for LifeSignals LX1550 Multiparameter Remote Monitoring Platform

By

Published : July 27, 2021 - 20:20

    • Link copied

Further validation of ability to deliver continuous remote patient vital signs monitoring within both hospital and home settings.

FREMONT, Calif., July 27, 2021 /PRNewswire/ -- LifeSignals Inc., today announced it has received FDA Class II 510 (k) approval for the LifeSignals LX1550 Multiparameter Remote Monitoring Platform. This follows recent CE marking and is further validation of LifeSignals' drive to create innovative wireless platforms which can be used by clinicians for the continuous collection of patient physiological data at home and in healthcare settings.

The LifeSignals LX1550 enables remote wireless monitoring of patient vital signs
The LifeSignals LX1550 enables remote wireless monitoring of patient vital signs

Central to the platform is a single-use wearable multiparameter biosensor that records Electrocardiography (2-channel ECG), Heart Rate, Respiration Rate, Skin Temperature and Body Posture data for up to five days. The encrypted physiological data can then be transmitted with high reliability from the biosensor, via a relay app to a secure cloud-based platform. Clinicians and Care Providers can access the cloud-based remote monitoring dashboard to view patient physiological data and manage alert settings.

The Remote Monitoring Platform is designed to enable healthtech companies to rapidly enhance their product and service portfolios to provide vital sign monitoring to the widest possible patient base, from any location. The relay app and dashboard are developer-friendly with ready-to-deploy software development kit APIs and is suitable for large scale implementation.

"COVID-19 has broken down the barriers to remote patient monitoring globally and I am proud of how the LifeSignals team has responded to develop the Platform in such a short space of time," says Surendar Magar, Founder and CEO. "This FDA 510 (k) approval marks another major milestone in the company's development and mission. It has already been implemented successfully in hospitals for monitoring COVID-19 patients in India and is being rolled out in Europe, UK, Singapore and the Philippines. Our focus now is to rapidly introduce low-cost remote vital sign monitoring to US healthtech companies looking to expand their services and improve patient care."

www.lifesignals.com

Photo- https://mma.prnasia.com/media2/1582121/lifesignals.jpg?p=medium600

More from Headlines